SQI Diagnostics explores strategic alternatives

Mon Nov 19, 2012 8:39am EST

Nov 19 (Reuters) - Canadian life sciences company SQI Diagnostics Inc said it is exploring strategic alternatives, including a sale or merger.

Toronto-based SQI said it has appointed a committee that will review the interests it has received.

SQI intends to actively explore these and other alternatives, including strategic alliances, the company said in a statement.

Investment bank Cantor Fitzgerald is advising the company.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.